Healthcare Sector Stocks
The Healthcare sector has a total of 1055 stocks, with a combined market cap of $9.2 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 46.20.
Market Cap
9.2T
Revenue
4.59T
Profits
199.17B
PE Ratio
46.20
Profit Margin
4.34%
Dividend Yield
0.38%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | 1.86% | 3,298,257 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 633.19B | 3.57% | 7,999,902 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 461.26B | 3.99% | 7,114,423 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 386.29B | -0.28% | 3,931,597 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 319.99B | 3.34% | 7,833,992 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 301.34B | 6.14% | 2,379,583 | 60.44B |
| 7 | NVS | Novartis AG | 292.06B | 3.74% | 1,588,015 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 225.09B | 3.40% | 12,080,180 | 50.57B |
| 9 | AMGN | Amgen Inc. | 201.93B | 3.55% | 2,487,758 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 194.52B | 1.97% | 2,321,760 | 45.20B |
| 11 | ABT | Abbott Laboratories | 166.17B | 3.49% | 10,682,742 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 162.98B | 4.21% | 8,090,828 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 150.88B | 5.87% | 3,141,664 | 10.58B |
| 14 | DHR | Danaher Corporation | 140.09B | 2.17% | 4,035,505 | 24.78B |
| 15 | PFE | Pfizer Inc. | 138.61B | 1.84% | 53,203,237 | 63.32B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 134.02B | 6.03% | 1,864,703 | 12.22B |
| 17 | CVS | CVS Health Corporation | 133.62B | -0.09% | 5,522,735 | 405.62B |
| 18 | SYK | Stryker Corporation | 125.18B | 4.20% | 2,609,778 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 118.71B | 4.16% | 10,003,365 | 48.48B |
| 20 | GSK | GSK plc | 106.71B | 4.60% | 3,802,644 | 43.29B |
| 21 | MDT | Medtronic plc | 106.49B | 5.04% | 9,722,952 | 36.36B |
| 22 | SNY | Sanofi | 103.36B | 3.68% | 3,459,474 | 54.60B |
| 23 | MCK | McKesson Corporation | 92.06B | 2.37% | 952,671 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 91.07B | 4.39% | 1,628,883 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 90.75B | 0.41% | 1,627,359 | 200.42B |
| 26 | CI | The Cigna Group | 76.12B | 3.86% | 2,108,847 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 67.09B | 4.83% | 26,354,200 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 66.56B | 4.73% | 1,071,577 | 14.92B |
| 29 | ARGX | argenx SE | 58.73B | 3.32% | 381,208 | 4.74B |
| 30 | COR | Cencora, Inc. | 57.69B | 2.80% | 1,466,649 | 328.68B |
| 31 | MDLN | Medline Inc. | 56.74B | 3.50% | 9,699,730 | 29.14B |
| 32 | CAH | Cardinal Health, Inc. | 55.96B | 0.51% | 2,039,274 | 250.74B |
| 33 | EW | Edwards Lifesciences Corporation | 54.34B | 2.59% | 3,227,673 | 6.30B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 51.79B | 5.14% | 3,515,152 | 28.34B |
| 35 | HUM | Humana Inc. | 47.63B | -3.09% | 1,399,820 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.00B | 3.76% | 813,895 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 43.56B | 3.39% | 2,040,522 | 22.23B |
| 38 | HLN | Haleon plc | 42.46B | 4.47% | 9,191,000 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.76B | 3.68% | 1,093,281 | 4.29B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 40.34B | 3.59% | 4,815,427 | 17.35B |
| 41 | RVMD | Revolution Medicines, Inc. | 40.23B | 0.92% | 3,190,771 | - |
| 42 | NTRA | Natera, Inc. | 40.00B | 1.10% | 1,273,866 | 2.50B |
| 43 | WAT | Waters Corporation | 37.24B | 0.31% | 749,043 | 3.77B |
| 44 | A | Agilent Technologies, Inc. | 36.91B | -2.02% | 2,194,238 | 7.23B |
| 45 | IQV | IQVIA Holdings Inc. | 34.55B | 1.89% | 1,229,469 | 16.63B |
| 46 | CNC | Centene Corporation | 33.51B | -0.72% | 3,873,022 | 178.33B |
| 47 | ALC | Alcon Inc. | 33.47B | 4.25% | 1,904,964 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 33.27B | 3.57% | 3,245,106 | 2.44B |
| 49 | ONC | BeOne Medicines AG | 33.09B | 2.38% | 294,949 | 5.70B |
| 50 | BIIB | Biogen Inc. | 31.91B | 3.04% | 1,155,099 | 9.94B |
| 51 | MRNA | Moderna, Inc. | 31.65B | 10.01% | 14,111,435 | 2.23B |
| 52 | ZTS | Zoetis Inc. | 31.36B | 3.24% | 4,360,846 | 9.53B |
| 53 | VEEV | Veeva Systems Inc. | 31.31B | 4.62% | 2,574,585 | 3.32B |
| 54 | RMD | ResMed Inc. | 30.27B | 4.24% | 1,144,252 | 5.54B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 29.82B | 1.09% | 4,515,583 | 20.98B |
| 56 | ILMN | Illumina, Inc. | 28.55B | 2.60% | 2,941,434 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 27.49B | 3.47% | 3,299,074 | 4.82B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.44B | 0.62% | 177,494 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 26.39B | 1.99% | 931,156 | 20.34B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.84B | 0.20% | 547,206 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.27B | 0.29% | 5,080,059 | 8.26M |
| 62 | BNTX | BioNTech SE | 24.67B | 3.86% | 1,390,437 | 3.23B |
| 63 | INSM | Insmed Incorporated | 24.19B | 4.30% | 2,771,288 | 819.56M |
| 64 | DGX | Quest Diagnostics Incorporated | 23.88B | -0.14% | 869,666 | 11.28B |
| 65 | UTHR | United Therapeutics Corporation | 23.60B | 1.60% | 534,362 | 3.17B |
| 66 | LH | Labcorp Holdings Inc. | 23.53B | 1.09% | 633,027 | 14.14B |
| 67 | INCY | Incyte Corporation | 23.35B | 2.68% | 2,632,374 | 5.36B |
| 68 | GH | Guardant Health, Inc. | 22.27B | -1.63% | 3,447,575 | 1.08B |
| 69 | STE | STERIS plc | 21.27B | 2.78% | 537,079 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.45B | 3.21% | 9,348,057 | 14.56B |
| 71 | GMAB | Genmab A/S | 17.61B | 3.17% | 1,414,961 | 3.90B |
| 72 | THC | Tenet Healthcare Corporation | 17.55B | 6.55% | 2,106,752 | 21.46B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.52B | 3.87% | 1,251,021 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 17.05B | 2.51% | 552,424 | 998.25M |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 16.92B | 3.92% | 2,288,767 | 8.41B |
| 76 | MEDP | Medpace Holdings, Inc. | 15.92B | 2.20% | 356,558 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.28B | 2.51% | 765,171 | 4.44B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.12B | 3.58% | 3,179,425 | 579.96M |
| 79 | DVA | DaVita Inc. | 15.08B | 3.02% | 842,345 | 13.84B |
| 80 | COO | The Cooper Companies, Inc. | 14.47B | 3.13% | 3,520,868 | 4.23B |
| 81 | BTSG | BrightSpring Health Services, Inc. | 14.38B | -1.17% | 2,242,636 | 13.65B |
| 82 | EXEL | Exelixis, Inc. | 14.04B | 3.50% | 2,364,017 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.55B | -0.10% | 1,367,001 | 8.26B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 13.52B | 3.30% | 2,286,094 | 1.06B |
| 85 | ICLR | ICON Public Limited Company | 13.26B | -1.14% | 938,189 | 8.27B |
| 86 | ALGN | Align Technology, Inc. | 13.21B | 1.67% | 1,361,744 | 4.10B |
| 87 | SNN | Smith & Nephew plc | 12.77B | 5.29% | 1,705,743 | 6.16B |
| 88 | RVTY | Revvity, Inc. | 12.69B | 0.82% | 972,331 | 2.90B |
| 89 | FMS | Fresenius Medical Care AG | 12.65B | 2.93% | 1,242,807 | 22.32B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 12.57B | 1.52% | 854,222 | 708.24M |
| 91 | PEN | Penumbra, Inc. | 12.53B | 0.68% | 296,718 | 1.45B |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.49B | 3.78% | 5,689,276 | 4.89B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.18B | 2.67% | 222,389 | 1.13B |
| 94 | MOH | Molina Healthcare, Inc. | 11.97B | -1.15% | 775,114 | 43.10B |
| 95 | SMMT | Summit Therapeutics Inc. | 11.97B | 7.23% | 7,104,907 | - |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.83B | 4.41% | 1,703,169 | 622.01M |
| 97 | RDY | Dr. Reddy's Laboratories Limited | 11.78B | 2.79% | 2,176,360 | 3.58B |
| 98 | CYTK | Cytokinetics, Incorporated | 11.74B | 1.44% | 2,030,295 | 105.82M |
| 99 | BAX | Baxter International Inc. | 11.70B | 4.43% | 6,546,027 | 11.32B |
| 100 | ABVX | ABIVAX Société Anonyme | 11.66B | 9.12% | 4,020,643 | 5.67M |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 11.40B | 2.02% | 1,483,584 | 3.24B |
| 102 | PODD | Insulet Corporation | 11.39B | 2.94% | 1,505,945 | 2.90B |
| 103 | CRL | Charles River Laboratories International, Inc. | 11.11B | 0.70% | 845,345 | 4.03B |
| 104 | KRYS | Krystal Biotech, Inc. | 11.06B | 0.94% | 235,190 | 417.30M |
| 105 | TECH | Bio-Techne Corporation | 11.04B | -0.24% | 7,826,270 | 1.21B |
| 106 | GMED | Globus Medical, Inc. | 10.88B | 5.48% | 1,752,573 | 3.10B |
| 107 | TEM | Tempus AI, Inc. | 10.82B | -2.16% | 5,966,498 | 1.36B |
| 108 | EHC | Encompass Health Corporation | 10.56B | 5.00% | 1,134,416 | 6.07B |
| 109 | APGE | Apogee Therapeutics, Inc. | 9.96B | 0.11% | 2,998,799 | - |
| 110 | IBRX | ImmunityBio, Inc. | 9.89B | 2.61% | 14,674,825 | 140.98M |
| 111 | HSIC | Henry Schein, Inc. | 9.85B | 2.26% | 2,161,831 | 13.38B |
| 112 | NUVL | Nuvalent, Inc. | 9.77B | 0.11% | 1,297,596 | - |
| 113 | ENSG | The Ensign Group, Inc. | 9.75B | 2.06% | 619,607 | 5.27B |
| 114 | OSCR | Oscar Health, Inc. | 9.69B | 0.88% | 8,008,389 | 13.30B |
| 115 | CORT | Corcept Therapeutics Incorporated | 9.68B | 1.96% | 771,933 | 769.10M |
| 116 | UHS | Universal Health Services, Inc. | 9.58B | 5.15% | 1,311,126 | 17.76B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 9.42B | 3.17% | 1,566,162 | 1.51B |
| 118 | BRKR | Bruker Corporation | 9.38B | 1.65% | 3,646,962 | 3.46B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.34B | -0.60% | 788,344 | 51.48M |
| 120 | ALKS | Alkermes plc | 9.10B | 5.53% | 1,653,856 | 1.56B |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.88B | -0.34% | 358,320 | 7.46M |
| 122 | GKOS | Glaukos Corporation | 8.71B | 7.83% | 1,241,013 | 551.35M |
| 123 | HIMS | Hims & Hers Health, Inc. | 8.52B | -2.05% | 16,473,434 | 2.37B |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 8.46B | 5.15% | 708,388 | 74.06M |
| 125 | PCVX | Vaxcyte, Inc. | 8.43B | 4.12% | 1,713,683 | - |
| 126 | QGEN | Qiagen N.V. | 8.29B | 2.48% | 1,625,900 | 2.10B |
| 127 | ATR | AptarGroup, Inc. | 8.10B | 1.38% | 468,388 | 3.87B |
| 128 | RGEN | Repligen Corporation | 8.03B | 2.45% | 981,602 | 763.34M |
| 129 | HQY | HealthEquity, Inc. | 7.97B | 3.27% | 986,246 | 1.34B |
| 130 | IMVT | Immunovant, Inc. | 7.96B | 1.70% | 1,048,551 | - |
| 131 | BIO | Bio-Rad Laboratories, Inc. | 7.94B | -0.08% | 344,674 | 2.59B |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.82B | 3.41% | 960,020 | 217.17M |
| 133 | MIRM | Mirum Pharmaceuticals, Inc. | 7.66B | 4.26% | 652,999 | 569.61M |
| 134 | TGTX | TG Therapeutics, Inc. | 7.56B | -0.39% | 3,075,219 | 700.35M |
| 135 | SYRE | Spyre Therapeutics, Inc. | 7.52B | -2.54% | 973,913 | - |
| 136 | LNTH | Lantheus Holdings, Inc. | 7.15B | 0.85% | 511,078 | 1.55B |
| 137 | AVTR | Avantor, Inc. | 7.05B | 3.10% | 8,327,588 | 6.55B |
| 138 | PACS | PACS Group, Inc. | 7.04B | 0.36% | 1,081,135 | 5.43B |
| 139 | LQDA | Liquidia Corporation | 7.02B | -0.49% | 1,405,600 | 288.07M |
| 140 | PTCT | PTC Therapeutics, Inc. | 6.91B | 2.41% | 6,778,019 | 827.11M |
| 141 | COGT | Cogent Biosciences, Inc. | 6.61B | 0.55% | 1,858,798 | - |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.58B | 3.86% | 1,726,048 | - |
| 143 | HNGE | Hinge Health, Inc. | 6.50B | -1.20% | 1,112,788 | 646.34M |
| 144 | CHE | Chemed Corporation | 6.47B | 1.83% | 173,927 | 2.54B |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.33B | 2.42% | 368,156 | 274.48M |
| 146 | GRFS | Grifols, S.A. | 6.27B | 1.13% | 1,369,447 | 8.58B |
| 147 | CGON | CG Oncology, Inc. | 6.21B | -0.75% | 792,245 | 5.07M |
| 148 | TWST | Twist Bioscience Corporation | 6.18B | -2.94% | 1,523,938 | 409.48M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.12B | 3.69% | 493,847 | 5.21B |
| 150 | TFX | Teleflex Incorporated | 5.93B | 3.27% | 673,199 | 2.13B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.89B | 1.09% | 1,462,538 | 7.50M |
| 152 | DFTX | Definium Therapeutics, Inc. | 5.87B | 1.82% | 2,363,067 | - |
| 153 | CRSP | CRISPR Therapeutics AG | 5.79B | 8.02% | 2,931,689 | 4.10M |
| 154 | LEGN | Legend Biotech Corporation | 5.79B | 0.07% | 1,407,015 | 1.14B |
| 155 | BLTE | Belite Bio, Inc | 5.77B | 3.04% | 109,393 | - |
| 156 | ERAS | Erasca, Inc. | 5.74B | 3.07% | 4,618,705 | - |
| 157 | BLLN | BillionToOne, Inc. | 5.54B | -1.62% | 611,541 | 354.54M |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.47B | 1.06% | 1,544,888 | 3.05B |
| 159 | MANE | Veradermics, Incorporated | 5.42B | 0.98% | 582,498 | - |
| 160 | RDNT | RadNet, Inc. | 5.41B | 4.77% | 1,693,572 | 2.14B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.29B | 1.03% | 1,698,997 | 536.20M |
| 162 | CELC | Celcuity Inc. | 5.26B | 3.31% | 906,231 | - |
| 163 | STVN | Stevanato Group S.p.A. | 5.19B | 3.60% | 337,541 | 1.39B |
| 164 | CAI | Caris Life Sciences, Inc. | 5.17B | -2.40% | 2,927,412 | 907.29M |
| 165 | DNTH | Dianthus Therapeutics, Inc. | 5.16B | 4.58% | 753,172 | 1.34M |
| 166 | ORKA | Oruka Therapeutics, Inc. | 5.14B | -8.66% | 4,523,935 | - |
| 167 | SHC | Sotera Health Company | 5.11B | 1.01% | 3,085,191 | 1.19B |
| 168 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.96B | 2.61% | 626,287 | 754.05M |
| 169 | TXG | 10x Genomics, Inc. | 4.95B | -0.10% | 2,773,161 | 638.78M |
| 170 | ALHC | Alignment Healthcare, Inc. | 4.92B | -0.87% | 5,434,215 | 4.26B |
| 171 | INDV | Indivior Pharmaceuticals, Inc. | 4.85B | -1.12% | 1,488,830 | 1.29B |
| 172 | LIVN | LivaNova PLC | 4.59B | 1.38% | 517,429 | 1.43B |
| 173 | VCYT | Veracyte, Inc. | 4.55B | -4.63% | 1,149,997 | 541.74M |
| 174 | WAY | Waystar Holding Corp. | 4.50B | 9.47% | 6,828,281 | 1.16B |
| 175 | NVST | Envista Holdings Corporation | 4.50B | 1.69% | 1,831,004 | 2.81B |
| 176 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.45B | 9.18% | 2,176,658 | 18.07M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | 3.06% | 1,549,042 | 1.10B |
| 178 | MMED | MiniMed Group, Inc. | 4.38B | 2.63% | 447,200 | 3.10B |
| 179 | LFST | LifeStance Health Group, Inc. | 4.37B | -1.40% | 5,079,780 | 1.49B |
| 180 | VKTX | Viking Therapeutics, Inc. | 4.35B | -0.11% | 2,487,336 | - |
| 181 | TNGX | Tango Therapeutics, Inc. | 4.26B | 2.54% | 2,307,381 | 56.99M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 4.26B | 1.05% | 793,162 | - |
| 183 | MMSI | Merit Medical Systems, Inc. | 4.24B | 2.36% | 638,533 | 1.54B |
| 184 | IRTC | iRhythm Holdings, Inc. | 4.16B | 1.60% | 557,663 | 787.85M |
| 185 | DNLI | Denali Therapeutics Inc. | 4.10B | -0.58% | 1,541,527 | - |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 4.08B | 3.70% | 1,270,477 | 2.23B |
| 187 | NAMS | NewAmsterdam Pharma Company N.V. | 4.07B | -0.97% | 1,202,489 | 22.57M |
| 188 | RLAY | Relay Therapeutics, Inc. | 4.06B | 5.01% | 3,172,833 | 10.68M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.04B | 0.25% | 255,239 | 803.79M |
| 190 | DOCS | Doximity, Inc. | 4.00B | 1.25% | 3,621,463 | 644.86M |
| 191 | ICUI | ICU Medical, Inc. | 3.87B | 4.39% | 404,631 | 2.16B |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.03% | 1,616,200 | 596.96M |
| 193 | RCUS | Arcus Biosciences, Inc. | 3.81B | 4.88% | 1,325,784 | 236.00M |
| 194 | DYN | Dyne Therapeutics, Inc. | 3.81B | 5.87% | 2,164,719 | - |
| 195 | GPCR | Structure Therapeutics Inc. | 3.80B | 2.55% | 592,486 | - |
| 196 | BKD | Brookdale Senior Living Inc. | 3.79B | 0.32% | 1,905,254 | 3.00B |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.77B | 6.56% | 302,540 | - |
| 198 | WRBY | Warby Parker Inc. | 3.59B | -0.37% | 2,158,212 | 890.57M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.58B | 4.09% | 1,206,186 | 225.27M |
| 200 | OGN | Organon & Co. | 3.56B | 0.15% | 1,508,000 | 6.16B |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.48B | 2.17% | 909,027 | - |
| 202 | BEAM | Beam Therapeutics Inc. | 3.46B | 3.91% | 2,316,245 | 164.01M |
| 203 | PRVA | Privia Health Group, Inc. | 3.45B | 1.79% | 938,255 | 2.25B |
| 204 | OPCH | Option Care Health, Inc. | 3.44B | 4.09% | 2,025,619 | 5.67B |
| 205 | NHC | National HealthCare Corporation | 3.41B | 2.69% | 105,553 | 1.53B |
| 206 | HAE | Haemonetics Corporation | 3.41B | 0.29% | 1,329,863 | 1.33B |
| 207 | ADPT | Adaptive Biotechnologies Corporation | 3.39B | -5.27% | 3,470,889 | 295.41M |
| 208 | ALMS | Alumis Inc. | 3.38B | -0.53% | 1,819,175 | 8.40M |
| 209 | RARE | Ultragenyx Pharmaceutical Inc. | 3.29B | 3.37% | 1,239,229 | 670.00M |
| 210 | ITGR | Integer Holdings Corporation | 3.23B | 0.60% | 484,867 | 1.86B |
| 211 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -0.12% | 1,198,180 | 415.62M |
| 212 | RGC | Regencell Bioscience Holdings Limited | 3.16B | -20.67% | 940,500 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.01B | 4.32% | 1,037,328 | 865.00K |
| 214 | GRAL | GRAIL, Inc. | 2.97B | 1.47% | 337,734 | 156.12M |
| 215 | VERA | Vera Therapeutics, Inc. | 2.96B | -3.42% | 5,143,973 | - |
| 216 | ACHC | Acadia Healthcare Company, Inc. | 2.93B | 2.11% | 4,504,436 | 3.37B |
| 217 | IRON | Disc Medicine, Inc. | 2.91B | 1.75% | 985,673 | - |
| 218 | QURE | uniQure N.V. | 2.87B | -7.44% | 2,811,025 | 18.09M |
| 219 | KLRA | Kailera Therapeutics, Inc. | 2.85B | 5.62% | 392,305 | - |
| 220 | TARS | Tarsus Pharmaceuticals, Inc. | 2.82B | 7.47% | 1,783,219 | 535.08M |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.79B | 1.34% | 969,031 | 776.83M |
| 222 | SLS | SELLAS Life Sciences Group, Inc. | 2.79B | 12.89% | 17,275,558 | - |
| 223 | CLOV | Clover Health Investments, Corp. | 2.77B | -2.41% | 5,901,932 | 2.21B |
| 224 | MBX | MBX Biosciences, Inc. | 2.75B | 3.36% | 828,662 | - |
| 225 | IMNM | Immunome, Inc. | 2.67B | 9.87% | 1,869,683 | 4.02M |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.66B | -0.31% | 565,088 | 1.46B |
| 227 | ESTA | Establishment Labs Holdings Inc. | 2.63B | 0.02% | 440,015 | 229.58M |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.55B | 1.82% | 2,202,177 | - |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.50B | 1.97% | 4,860,048 | 885.72M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.48B | 0.25% | 1,403,919 | 71.78M |
| 231 | ABCL | AbCellera Biologics Inc. | 2.48B | 6.71% | 8,464,236 | 79.21M |
| 232 | NTLA | Intellia Therapeutics, Inc. | 2.45B | 1.86% | 4,165,274 | 66.09M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | 2.98% | 700,756 | - |
| 234 | AXGN | Axogen, Inc. | 2.44B | 4.25% | 2,409,581 | 238.11M |
| 235 | ASTH | Astrana Health, Inc. | 2.44B | -1.28% | 1,051,837 | 3.53B |
| 236 | HTFL | HeartFlow, Inc. | 2.41B | -8.94% | 1,892,447 | 191.42M |
| 237 | KOD | Kodiak Sciences Inc. | 2.41B | 3.49% | 1,005,980 | - |
| 238 | BHVN | Biohaven Ltd. | 2.40B | 1.27% | 3,530,657 | - |
| 239 | NKTR | Nektar Therapeutics | 2.40B | 10.33% | 1,120,778 | 55.63M |
| 240 | VCEL | Vericel Corporation | 2.40B | 4.05% | 640,667 | 292.09M |
| 241 | TMDX | TransMedics Group, Inc. | 2.38B | 1.49% | 832,640 | 635.89M |
| 242 | PGNY | Progyny, Inc. | 2.37B | 2.61% | 942,933 | 1.29B |
| 243 | PHVS | Pharvaris N.V. | 2.37B | -0.27% | 478,098 | - |
| 244 | LMAT | LeMaitre Vascular, Inc. | 2.35B | 4.19% | 350,540 | 256.28M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | 2.62% | 561,926 | 1.09B |
| 246 | XRAY | DENTSPLY SIRONA Inc. | 2.33B | 5.05% | 4,796,931 | 3.68B |
| 247 | AGIO | Agios Pharmaceuticals, Inc. | 2.23B | 1.38% | 791,098 | 66.05M |
| 248 | SGRY | Surgery Partners, Inc. | 2.23B | 3.80% | 1,476,760 | 3.34B |
| 249 | GENB | Generate Biomedicines, Inc. | 2.23B | 5.52% | 833,212 | 30.30M |
| 250 | KARD | Kardigan, Inc. | 2.18B | 1.00% | 342,786 | - |
| 251 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | 3.50% | 1,012,967 | 899.11M |
| 252 | ZLAB | Zai Lab Limited | 2.15B | -0.16% | 389,048 | 453.28M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.15B | 2.37% | 831,920 | 1.93B |
| 254 | VRDN | Viridian Therapeutics, Inc. | 2.14B | 4.98% | 1,950,143 | 70.92M |
| 255 | OCUL | Ocular Therapeutix, Inc. | 2.11B | 1.80% | 1,834,116 | 52.04M |
| 256 | UFPT | UFP Technologies, Inc. | 2.11B | 1.24% | 244,173 | 608.85M |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.10B | 6.15% | 321,854 | - |
| 258 | TSHA | Taysha Gene Therapies, Inc. | 2.09B | -1.80% | 2,325,112 | 7.47M |
| 259 | ADMA | ADMA Biologics, Inc. | 2.07B | 3.95% | 4,366,986 | 509.86M |
| 260 | GLUE | Monte Rosa Therapeutics, Inc. | 2.05B | 0.79% | 1,391,613 | 42.95M |
| 261 | STOK | Stoke Therapeutics, Inc. | 2.04B | -0.03% | 1,013,196 | 32.08M |
| 262 | SRPT | Sarepta Therapeutics, Inc. | 2.04B | 5.93% | 4,787,635 | 2.18B |
| 263 | NEOG | Neogen Corporation | 2.03B | 0.32% | 1,059,996 | 870.56M |
| 264 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.03B | 1.78% | 1,392,714 | -665.00K |
| 265 | PLSE | Pulse Biosciences, Inc. | 2.02B | 3.09% | 182,735 | 751.00K |
| 266 | RXRX | Recursion Pharmaceuticals, Inc. | 2.02B | 3.54% | 32,680,470 | 66.41M |
| 267 | PGEN | Precigen, Inc. | 2.01B | 7.43% | 4,766,041 | 31.60M |
| 268 | HCM | HUTCHMED (China) Limited | 2.01B | 6.12% | 104,607 | 548.51M |
| 269 | BFLY | Butterfly Network, Inc. | 2.01B | -3.15% | 8,694,644 | 102.92M |
| 270 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -1.20% | 2,640,635 | 298.30M |
| 271 | WGS | GeneDx Holdings Corp. | 2.00B | -5.86% | 925,814 | 442.68M |
| 272 | NVCR | NovoCure Limited | 1.99B | 9.00% | 1,953,388 | 674.41M |
| 273 | LKFT | Lakefront Biotherapeutics NV | 1.99B | 2.67% | 159,237 | 1.20B |
| 274 | SION | Sionna Therapeutics, Inc. | 1.99B | 5.64% | 329,043 | - |
| 275 | NUVB | Nuvation Bio Inc. | 1.98B | 5.17% | 6,332,074 | 143.05M |
| 276 | AVAH | Aveanna Healthcare Holdings Inc. | 1.98B | 2.71% | 2,548,244 | 2.52B |
| 277 | NEO | NeoGenomics, Inc. | 1.97B | 1.27% | 2,178,943 | 745.97M |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.97B | 1.15% | 639,469 | 367.34M |
| 279 | ABSI | Absci Corporation | 1.97B | 4.59% | 5,278,500 | 1.84M |
| 280 | OMCL | Omnicell, Inc. | 1.96B | 2.62% | 479,142 | 1.23B |
| 281 | NBTX | Nanobiotix S.A. | 1.95B | -2.28% | 94,514 | 38.27M |
| 282 | SNDX | Syndax Pharmaceuticals, Inc. | 1.93B | 4.45% | 2,197,351 | 217.17M |
| 283 | IOVA | Iovance Biotherapeutics, Inc. | 1.92B | 8.56% | 20,542,153 | 285.61M |
| 284 | ADUS | Addus HomeCare Corporation | 1.92B | 2.88% | 296,590 | 1.45B |
| 285 | ZYME | Zymeworks Inc. | 1.92B | 2.29% | 563,781 | 81.26M |
| 286 | ATAI | AtaiBeckley Inc. | 1.91B | 6.35% | 11,327,605 | 3.49M |
| 287 | BCAX | Bicara Therapeutics Inc. | 1.91B | 0.31% | 924,138 | - |
| 288 | TRLV | Trulieve Cannabis Corp. | 1.88B | 2.52% | 1,054,550 | 1.17B |
| 289 | RAPP | Rapport Therapeutics, Inc. | 1.86B | -1.07% | 254,369 | 20.00M |
| 290 | GHRS | GH Research PLC | 1.85B | 2.23% | 168,283 | - |
| 291 | URGN | UroGen Pharma Ltd. | 1.85B | 0.21% | 821,798 | 140.49M |
| 292 | AGL | agilon health, inc. | 1.85B | -0.65% | 190,341 | 5.82B |
| 293 | ANAB | AnaptysBio, Inc. | 1.85B | -3.07% | 1,355,585 | 232.39M |
| 294 | DMRA | Damora Therapeutics, Inc. | 1.85B | 10.67% | 761,150 | - |
| 295 | MESO | Mesoblast Limited | 1.84B | 2.06% | 191,681 | 65.38M |
| 296 | CMPS | COMPASS Pathways plc | 1.84B | 2.48% | 4,103,663 | - |
| 297 | BHC | Bausch Health Companies Inc. | 1.83B | 2.73% | 3,279,428 | 10.53B |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.82B | 3.59% | 572,932 | 923.71M |
| 299 | TYRA | Tyra Biosciences, Inc. | 1.82B | 4.11% | 645,962 | - |
| 300 | ALMR | Alamar Biosciences, Inc. | 1.80B | -0.73% | 252,328 | 87.16M |
| 301 | AKTS | Aktis Oncology, Inc. | 1.76B | 2.82% | 723,680 | 8.28M |
| 302 | MAZE | Maze Therapeutics, Inc. | 1.73B | 4.86% | 575,729 | 20.00M |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.73B | 0.16% | 699,721 | 1.85B |
| 304 | ZBIO | Zenas BioPharma, Inc. | 1.72B | -2.75% | 1,383,436 | 10.00M |
| 305 | VIR | Vir Biotechnology, Inc. | 1.69B | 5.02% | 1,159,872 | 65.50M |
| 306 | MPLT | MapLight Therapeutics, Inc. | 1.68B | 2.80% | 367,146 | - |
| 307 | TDOC | Teladoc Health, Inc. | 1.66B | 1.10% | 4,282,691 | 2.51B |
| 308 | IMCR | Immunocore Holdings plc | 1.65B | 2.65% | 954,707 | 412.81M |
| 309 | INVA | Innoviva, Inc. | 1.65B | 1.87% | 655,045 | 420.69M |
| 310 | AAPG | Ascentage Pharma Group International | 1.64B | 1.28% | 13,518 | 82.08M |
| 311 | FTRE | Fortrea Holdings Inc. | 1.63B | -1.71% | 1,371,980 | 2.71B |
| 312 | INNV | InnovAge Holding Corp. | 1.63B | 2.35% | 368,180 | 949.17M |
| 313 | AVBP | ArriVent BioPharma, Inc. | 1.61B | 0.49% | 515,615 | - |
| 314 | ATRC | AtriCure, Inc. | 1.61B | 6.93% | 1,545,460 | 552.16M |
| 315 | NVAX | Novavax, Inc. | 1.60B | 2.96% | 4,850,709 | 596.34M |
| 316 | HROW | Harrow, Inc. | 1.59B | -0.60% | 492,415 | 268.68M |
| 317 | SVRA | Savara Inc. | 1.58B | 2.64% | 1,531,756 | - |
| 318 | KMTS | Kestra Medical Technologies, Ltd. | 1.57B | 2.66% | 308,083 | 83.72M |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.57B | -0.94% | 1,391,926 | - |
| 320 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.56B | -1.79% | 1,723,826 | 204.73M |
| 321 | ARDT | Ardent Health, Inc. | 1.54B | 6.22% | 677,502 | 6.43B |
| 322 | SEPN | Septerna, Inc. | 1.53B | -1.76% | 475,768 | 72.26M |
| 323 | PRGO | Perrigo Company plc | 1.52B | 6.89% | 3,336,052 | 4.18B |
| 324 | CDNA | CareDx, Inc. | 1.51B | -0.21% | 855,779 | 412.82M |
| 325 | COAG | Hemab Therapeutics Holdings, Inc. | 1.45B | -4.62% | 251,804 | - |
| 326 | AHCO | AdaptHealth Corp. | 1.43B | 1.51% | 729,581 | 3.29B |
| 327 | INBX | Inhibrx Biosciences, Inc. | 1.43B | 2.78% | 215,098 | 1.30M |
| 328 | XERS | Xeris Biopharma Holdings, Inc. | 1.43B | 3.50% | 3,753,157 | 314.85M |
| 329 | PSNL | Personalis, Inc. | 1.43B | -1.23% | 3,788,091 | 64.52M |
| 330 | IART | Integra LifeSciences Holdings Corporation | 1.40B | 0.89% | 682,935 | 1.64B |
| 331 | MNKD | MannKind Corporation | 1.40B | 11.60% | 9,573,416 | 360.78M |
| 332 | STAA | STAAR Surgical Company | 1.38B | -1.28% | 508,759 | 290.38M |
| 333 | BLFS | BioLife Solutions, Inc. | 1.37B | -1.33% | 655,275 | 101.66M |
| 334 | ATEC | Alphatec Holdings, Inc. | 1.37B | 0.68% | 2,843,944 | 787.08M |
| 335 | IMTX | Immatics N.V. | 1.36B | 1.02% | 387,512 | 43.00M |
| 336 | INSP | Inspire Medical Systems, Inc. | 1.35B | 3.28% | 1,301,837 | 915.25M |
| 337 | NUTX | Nutex Health Inc. | 1.35B | 3.05% | 263,461 | 879.95M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.35B | 3.61% | 298,930 | 1.50B |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.35B | 4.54% | 862,634 | 3.42B |
| 340 | CAPR | Capricor Therapeutics, Inc. | 1.34B | 0.61% | 1,641,199 | 11.13M |
| 341 | PNTG | The Pennant Group, Inc. | 1.34B | 3.10% | 642,951 | 1.02B |
| 342 | OMDA | Omada Health, Inc. | 1.33B | -1.02% | 835,371 | 283.30M |
| 343 | AVLN | Avalyn Pharma Inc. | 1.32B | -1.46% | 582,507 | - |
| 344 | AHG | Akso Health Group | 1.30B | 0.66% | 2,290 | 14.84M |
| 345 | ARDX | Ardelyx, Inc. | 1.30B | 2.13% | 3,208,199 | 427.68M |
| 346 | ENOV | Enovis Corporation | 1.30B | 12.28% | 1,302,521 | 2.28B |
| 347 | IRMD | IRADIMED CORPORATION | 1.29B | 2.99% | 130,062 | 86.28M |
| 348 | MGTX | MeiraGTx Holdings plc | 1.29B | 8.75% | 1,121,345 | 79.76M |
| 349 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | 3.18% | 1,318,915 | - |
| 350 | JBIO | Jade Biosciences, Inc. | 1.28B | -1.38% | 1,204,531 | - |
| 351 | SDGR | Schrödinger, Inc. | 1.26B | 2.99% | 1,511,570 | 254.91M |
| 352 | QDEL | QuidelOrtho Corporation | 1.24B | 0.39% | 1,222,458 | 2.66B |
| 353 | ALVO | Alvotech | 1.22B | 0.84% | 479,403 | 562.04M |
| 354 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | 6.89% | 2,174,112 | - |
| 355 | WVE | Wave Life Sciences Ltd. | 1.20B | 7.19% | 4,361,423 | 71.80M |
| 356 | SANA | Sana Biotechnology, Inc. | 1.20B | 12.64% | 5,315,387 | - |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.20B | 3.23% | 480,470 | 796.33M |
| 358 | PRCT | PROCEPT BioRobotics Corporation | 1.20B | -10.40% | 1,737,908 | 322.02M |
| 359 | LMRI | Lumexa Imaging Holdings, Inc. | 1.19B | 7.25% | 1,347,093 | 1.03B |
| 360 | DRTS | Alpha Tau Medical Ltd. | 1.19B | 4.67% | 1,154,552 | - |
| 361 | AZTA | Azenta, Inc. | 1.19B | -1.34% | 518,048 | 596.48M |
| 362 | EYPT | EyePoint, Inc. | 1.17B | 5.91% | 1,490,930 | 7.61M |
| 363 | AVNS | Avanos Medical, Inc. | 1.17B | 1.22% | 1,390,472 | 715.90M |
| 364 | AORT | Artivion, Inc. | 1.16B | 1.78% | 698,420 | 458.69M |
| 365 | OPK | OPKO Health, Inc. | 1.15B | -0.65% | 2,156,200 | 581.12M |
| 366 | BIOA | BioAge Labs, Inc. | 1.12B | 3.46% | 418,606 | 10.32M |
| 367 | VOR | Vor Biopharma Inc. | 1.12B | 11.96% | 3,911,211 | - |
| 368 | XNCR | Xencor, Inc. | 1.11B | -2.47% | 919,419 | 97.36M |
| 369 | OLMA | Olema Pharmaceuticals, Inc. | 1.10B | 4.64% | 1,375,875 | - |
| 370 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -4.10% | 220,743 | - |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.10B | 1.46% | 386,550 | 787.69M |
| 372 | CERT | Certara, Inc. | 1.08B | 3.57% | 3,886,719 | 419.75M |
| 373 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | 2.03% | 1,074,820 | - |
| 374 | CRON | Cronos Group Inc. | 1.07B | - | 1,075,342 | 159.54M |
| 375 | SLDB | Solid Biosciences Inc. | 1.07B | 6.27% | 2,632,857 | - |
| 376 | TNDM | Tandem Diabetes Care, Inc. | 1.05B | -2.73% | 1,627,573 | 1.03B |
| 377 | EVO | Evotec SE | 1.05B | 1.75% | 26,342 | 859.03M |
| 378 | GDRX | GoodRx Holdings, Inc. | 1.03B | -0.33% | 1,405,354 | 787.89M |
| 379 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.85% | 2,630,000 | 69.64M |
| 380 | ETON | Eton Pharmaceuticals, Inc. | 1.03B | 2.38% | 527,912 | 86.93M |
| 381 | CNMD | CONMED Corporation | 1.02B | 3.27% | 436,998 | 1.37B |
| 382 | PCRX | Pacira BioSciences, Inc. | 999.04M | 1.44% | 370,490 | 734.86M |
| 383 | AVR | Anteris Technologies Global Corp. | 996.78M | 3.02% | 1,450,421 | 1.85M |
| 384 | AVTX | Avalo Therapeutics, Inc. | 990.34M | 8.96% | 1,815,832 | 59.00K |
| 385 | KURA | Kura Oncology, Inc. | 985.40M | 2.97% | 1,889,482 | 71.64M |
| 386 | PHAR | Pharming Group N.V. | 984.45M | 0.81% | 4,229 | 369.49M |
| 387 | DSGN | Design Therapeutics, Inc. | 976.83M | 6.68% | 1,578,324 | - |
| 388 | REPL | Replimune Group, Inc. | 972.08M | 3.21% | 2,844,698 | - |
| 389 | SLBT | SL Science Holding Limited | 968.13M | 34.61% | 1,216,225 | - |
| 390 | ABUS | Arbutus Biopharma Corporation | 962.01M | 2.96% | 2,607,717 | 191.45M |
| 391 | LBRX | LB Pharmaceuticals Inc | 958.66M | 4.83% | 406,031 | - |
| 392 | DBVT | DBV Technologies S.A. | 951.61M | 0.57% | 195,922 | 5.74M |
| 393 | JANX | Janux Therapeutics, Inc. | 947.70M | 6.00% | 1,037,770 | 13.73M |
| 394 | INMD | InMode Ltd. | 937.71M | 0.82% | 684,027 | 374.64M |
| 395 | ANNX | Annexon, Inc. | 894.58M | -1.62% | 2,561,836 | - |
| 396 | PHAT | Phathom Pharmaceuticals, Inc. | 889.62M | 6.26% | 889,300 | 204.89M |
| 397 | IVA | Inventiva S.A. | 885.58M | 5.96% | 1,832,849 | 7.94M |
| 398 | BVS | Bioventus Inc. | 875.44M | 6.40% | 701,199 | 576.30M |
| 399 | TBPH | Theravance Biopharma, Inc. | 872.79M | -0.29% | 1,619,569 | 109.78M |
| 400 | GERN | Geron Corporation | 872.47M | 7.09% | 10,548,071 | 196.12M |
| 401 | TALK | Talkspace, Inc. | 871.07M | - | 2,697,837 | 238.37M |
| 402 | ANRO | Alto Neuroscience, Inc. | 869.63M | -0.64% | 438,526 | - |
| 403 | AMPH | Amphastar Pharmaceuticals, Inc. | 865.98M | -2.29% | 315,753 | 720.53M |
| 404 | AURA | Aura Biosciences, Inc. | 853.72M | 15.01% | 961,612 | - |
| 405 | OCS | Oculis Holding AG | 852.68M | 4.36% | 398,009 | 1.40M |
| 406 | SPRY | ARS Pharmaceuticals, Inc. | 850.04M | 7.81% | 1,796,362 | 98.99M |
| 407 | CTMX | CytomX Therapeutics, Inc. | 831.63M | 6.11% | 5,123,400 | 35.54M |
| 408 | HSTM | HealthStream, Inc. | 830.00M | 0.46% | 184,925 | 311.78M |
| 409 | ZVRA | Zevra Therapeutics, Inc. | 826.43M | 1.23% | 1,422,210 | 122.29M |
| 410 | ESPR | Esperion Therapeutics, Inc. | 813.48M | - | 7,879,309 | 418.24M |
| 411 | ODTX | Odyssey Therapeutics, Inc. | 801.48M | 0.78% | 206,823 | 1.06M |
| 412 | TENX | Tenax Therapeutics, Inc. | 789.88M | 16.33% | 3,894,945 | - |
| 413 | GMRS | GMR Solutions Inc. | 784.25M | -1.63% | 1,169,080 | 5.83B |
| 414 | ACRS | Aclaris Therapeutics, Inc. | 776.53M | 4.12% | 1,942,405 | 8.37M |
| 415 | SIBN | SI-BONE, Inc. | 758.82M | 1.85% | 474,024 | 206.22M |
| 416 | SSII | SS Innovations International, Inc. | 756.50M | -4.06% | 40,371 | 48.47M |
| 417 | BBNX | Beta Bionics, Inc. | 746.85M | 0.36% | 606,798 | 110.24M |
| 418 | CBLL | CeriBell, Inc. | 741.78M | -2.25% | 721,324 | 95.07M |
| 419 | CLYM | Climb Bio, Inc. | 738.66M | -2.97% | 1,176,673 | - |
| 420 | IMMX | Immix Biopharma, Inc. | 736.10M | 5.19% | 2,074,479 | - |
| 421 | CSTL | Castle Biosciences, Inc. | 731.26M | -2.43% | 175,502 | 339.92M |
| 422 | CADL | Candel Therapeutics, Inc. | 720.25M | -0.51% | 1,550,086 | - |
| 423 | ALLO | Allogene Therapeutics, Inc. | 717.92M | -1.42% | 9,136,219 | 22.00K |
| 424 | RIGL | Rigel Pharmaceuticals, Inc. | 716.40M | 1.12% | 472,684 | 299.77M |
| 425 | TECX | Tectonic Therapeutic, Inc. | 715.71M | 15.85% | 479,987 | - |
| 426 | IRWD | Ironwood Pharmaceuticals, Inc. | 712.78M | 5.10% | 2,651,088 | 361.51M |
| 427 | TCMD | Tactile Systems Technology, Inc. | 707.14M | 2.28% | 382,951 | 343.52M |
| 428 | PRME | Prime Medicine, Inc. | 698.99M | -0.51% | 5,602,752 | 4.03M |
| 429 | RGNX | REGENXBIO Inc. | 686.54M | 1.45% | 3,298,799 | 87.82M |
| 430 | CRMD | CorMedix Inc. | 686.45M | 3.31% | 1,043,607 | 400.05M |
| 431 | FDMT | 4D Molecular Therapeutics, Inc. | 679.59M | 2.44% | 1,002,630 | 88.24M |
| 432 | DNA | Ginkgo Bioworks Holdings, Inc. | 679.37M | 1.17% | 865,293 | 151.40M |
| 433 | EIKN | Eikon Therapeutics, Inc. | 678.90M | 2.37% | 457,409 | - |
| 434 | PHR | Phreesia, Inc. | 676.22M | 2.05% | 1,000,386 | 495.59M |
| 435 | TRAX | First Tracks Biotherapeutics, Inc. | 673.42M | 3.82% | 558,172 | - |
| 436 | OMER | Omeros Corporation | 671.64M | -1.38% | 1,375,488 | 9.89M |
| 437 | GYRE | Gyre Therapeutics, Inc. | 670.67M | 12.58% | 101,745 | 117.05M |
| 438 | DRUG | Bright Minds Biosciences Inc. | 659.11M | 1.59% | 234,693 | - |
| 439 | RLMD | Relmada Therapeutics, Inc. | 658.71M | -1.72% | 1,449,051 | - |
| 440 | ACHV | Achieve Life Sciences, Inc. | 657.02M | - | 1,712,856 | - |
| 441 | MNPR | Monopar Therapeutics Inc. | 655.07M | 2.90% | 188,240 | - |
| 442 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 649.67M | 3.97% | 401,580 | - |
| 443 | EVH | Evolent Health, Inc. | 642.27M | -0.52% | 3,568,429 | 1.89B |
| 444 | SGP | SpyGlass Pharma, Inc. | 640.25M | -2.41% | 120,708 | - |
| 445 | CERS | Cerus Corporation | 633.17M | 5.33% | 3,298,413 | 216.56M |
| 446 | BWAY | BrainsWay Ltd. | 626.08M | -0.65% | 81,602 | 56.22M |
| 447 | AGMB | AgomAb Therapeutics NV | 622.99M | 7.08% | 38,861 | - |
| 448 | ALT | Altimmune, Inc. | 614.54M | 0.32% | 4,077,524 | 36.00K |
| 449 | PROK | ProKidney Corp. | 613.18M | 7.41% | 1,597,041 | 889.00K |
| 450 | CTKB | Cytek Biosciences, Inc. | 592.76M | 0.22% | 889,754 | 204.17M |
| 451 | FLGT | Fulgent Genetics, Inc. | 592.15M | 0.14% | 184,268 | 320.35M |
| 452 | FTH | Faeth Therapeutics, Inc. | 590.85M | -3.13% | 185,854 | - |
| 453 | MDXG | MiMedx Group, Inc. | 588.34M | 1.28% | 662,464 | 389.42M |
| 454 | CBIO | Crescent Biopharma, Inc. | 567.88M | 0.06% | 265,925 | 11.88M |
| 455 | MYGN | Myriad Genetics, Inc. | 565.74M | -0.25% | 1,224,483 | 829.00M |
| 456 | CTNM | Contineum Therapeutics, Inc. | 564.53M | -0.92% | 378,660 | - |
| 457 | CLPT | ClearPoint Neuro, Inc. | 561.40M | - | 599,057 | 40.61M |
| 458 | EDIT | Editas Medicine, Inc. | 560.14M | 11.28% | 4,202,064 | 38.69M |
| 459 | NGNE | Neurogene Inc. | 558.44M | 4.31% | 362,882 | 925.00K |
| 460 | NNNN | Anbio Biotechnology | 557.42M | 2.83% | 40,498 | 8.65M |
| 461 | CTEV | Claritev Corporation | 556.44M | 0.74% | 78,815 | 978.76M |
| 462 | TLRY | Tilray Brands, Inc. | 551.09M | 4.29% | 5,593,996 | 858.28M |
| 463 | NPCE | NeuroPace, Inc. | 550.27M | 2.35% | 117,358 | 99.53M |
| 464 | ASMB | Assembly Biosciences, Inc. | 549.73M | 3.93% | 199,252 | 71.10M |
| 465 | ANGO | AngioDynamics, Inc. | 545.62M | -0.23% | 350,284 | 313.73M |
| 466 | ARVN | Arvinas, Inc. | 541.33M | 2.32% | 643,670 | 89.40M |
| 467 | STTK | Shattuck Labs, Inc. | 540.60M | 8.29% | 908,899 | 1.00M |
| 468 | KYTX | Kyverna Therapeutics, Inc. | 540.47M | 5.33% | 1,453,579 | - |
| 469 | XOMA | XOMA Royalty Corporation | 539.26M | 0.89% | 137,628 | 48.56M |
| 470 | CYH | Community Health Systems, Inc. | 528.27M | 10.17% | 4,247,286 | 12.29B |
| 471 | TOI | The Oncology Institute, Inc. | 527.91M | -4.17% | 1,281,864 | 545.76M |
| 472 | AQST | Aquestive Therapeutics, Inc. | 524.38M | -1.42% | 1,732,804 | 50.27M |
| 473 | WEAV | Weave Communications, Inc. | 523.54M | 2.65% | 1,254,129 | 248.72M |
| 474 | PACB | Pacific Biosciences of California, Inc. | 521.81M | -3.45% | 5,375,082 | 160.03M |
| 475 | CABA | Cabaletta Bio, Inc. | 520.14M | 6.69% | 8,593,041 | - |
| 476 | NVCT | Nuvectis Pharma, Inc. | 519.10M | 0.26% | 654,527 | - |
| 477 | RZLT | Rezolute, Inc. | 512.93M | -0.81% | 2,794,825 | - |
| 478 | KIDS | OrthoPediatrics Corp. | 512.42M | 3.37% | 122,304 | 243.30M |
| 479 | FBRX | Forte Biosciences, Inc. | 511.19M | -1.88% | 401,572 | - |
| 480 | OCGN | Ocugen, Inc. | 511.17M | 2.03% | 6,961,503 | 4.47M |
| 481 | NRC | NRC Health | 507.53M | 0.81% | 67,459 | 138.64M |
| 482 | PRTA | Prothena Corporation plc | 507.30M | 1.25% | 462,875 | 57.94M |
| 483 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 484 | STRO | Sutro Biopharma, Inc. | 504.24M | 0.63% | 524,925 | 99.61M |
| 485 | OVID | Ovid Therapeutics Inc. | 502.06M | 0.37% | 1,887,148 | 7.12M |
| 486 | ZURA | Zura Bio Limited | 491.14M | 3.19% | 908,275 | - |
| 487 | SLN | Silence Therapeutics plc | 490.76M | -1.05% | 696,707 | 839.00K |
| 488 | VALN | Valneva SE | 487.25M | 2.65% | 19,019 | 180.25M |
| 489 | PRLD | Prelude Therapeutics Incorporated | 486.96M | - | 326,571 | 16.72M |
| 490 | CCCC | C4 Therapeutics, Inc. | 475.44M | -0.92% | 2,624,586 | 34.86M |
| 491 | SGMT | Sagimet Biosciences Inc. | 469.93M | 2.01% | 834,215 | - |
| 492 | SRTA | Strata Critical Medical, Inc. | 468.11M | 2.46% | 1,328,237 | 228.58M |
| 493 | ARTV | Artiva Biotherapeutics, Inc. | 466.93M | -1.94% | 435,838 | 251.00K |
| 494 | EVMN | Evommune, Inc. | 466.80M | 1.09% | 1,344,528 | 10.00M |
| 495 | VMD | Viemed Healthcare, Inc. | 460.81M | 2.39% | 377,146 | 286.57M |
| 496 | DCTH | Delcath Systems, Inc. | 455.69M | 2.25% | 337,952 | 90.44M |
| 497 | EOLS | Evolus, Inc. | 454.40M | 2.37% | 534,868 | 301.79M |
| 498 | BNTC | Benitec Biopharma Inc. | 454.16M | 4.14% | 172,366 | - |
| 499 | MOBI | Mobia Medical, Inc. | 453.85M | 3.72% | 112,110 | 38.45M |
| 500 | SOPH | SOPHiA GENETICS SA | 448.84M | -4.29% | 386,209 | 81.18M |